Selim Aractingi is an expert in Dermatology at Hôpital Cochin (France). Selim Aractingi has authored 500 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 1,554 (community average: 125). How the SLR is computed.

LeadR Profile

Selim Aractingi Hôpital Cochin France
1 554 ScienceLeadR Reputation 1554
Network Map

Dermatology

Subspecialties: Oncology - Hematology - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1991 - 2026

Source: PubMed

Université Paris Cité

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 500

Citations

Citations: 11 518 1st author: 44 Last author: 115 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Peripheral serotonin regulates epidermal differentiation and dermal homeostasis.
PMID 42248507 — homeostasis, serotonin, dermatology
J Invest Dermatol20260
Continuous Intrathecal Infusion of Nivolumab in Advanced Melanoma With Concomitant Leptomeningeal Disease: Efficacy, Safety, and Pharmacokinetics.
PMID 41636506 — radiotherapy, safety, radiosurgery, melanoma, brain, neurosurgery, nivolumab, therapeutics, pharmacokinetics, spine
Neurosurgery20260
[Atypical fibroxanthoma].
PMID 41232973 — skin, surgery, plastic, neoplasms, mohs surgery
Ann Chir Plast Esthet20250
International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes.
PMID 41173425 — dermatitis, multiple chronic conditions, therapeutics, dermatology, dermatitis, atopic
J Am Acad Dermatol20250
Genetic landscape of non-UV-induced cutaneous squamous cell carcinomas.
PMID 41132030 — skin, cells, genes, carcinoma, squamous cell, neoplasms, pathology, ulcer, mutation, cutaneous squamous cell carcinoma
J Pathol20250

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

N/A 4
Phase 2 2
Phase 3 1
Phase 4 1

By status:

Completed 4
Recruiting 3
Withdrawn 1

By type:

Interventional 6
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 5

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Fetal Cell Receptors Repertoire
NCT06031714 — cells, quality control, interviews as topic, mothers, phlebotomy, blood, microscopy, electron, scanning transmission, cell survival, stem cells, ulcer, restraint, physical, varicose ulcer, rna, women
N/ARecruiting2024

LeadR Networks

Main global connection map